Preemption: FDA label preempts state tort law – Bureau of National Affairs responds
Preemption: FDA label preempts state tort law – Bureau of National Affairs responds
In January the Food and Drug Administration issued a new drug labeling rule, stating that its regulation preempts state tort and product liability laws with respect to prescription drugs. The Litigation Group at Bureau of National Affairs, explains why the FDA’s position is legally wrong and bad public policy in the article below.
Bookmark: 
